Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats

Br J Anaesth. 2004 Feb;92(2):277-9. doi: 10.1093/bja/aeh050.

Abstract

Background: To investigate the effects of propofol administration on acute lung injury in endotoxin-induced shock in rats.

Methods: Seventy-six male Wistar rats were randomly assigned to one of five groups: (i) saline control; (ii) endotoxin alone (receiving lipopolysaccharide (LPS) 8 mg kg(-1) i.v.); (iii) pretreatment with propofol 1 h before LPS; (iv) simultaneous treatment with propofol and LPS; (v) post-treatment with propofol 1 h after LPS. During the 5 h after LPS injection, survival rates were recorded. Lung tissue was sampled to measure values of nitrite/nitrates (NO(2-)/NO(3-)) and tumour necrosis factor (TNF)-alpha in bronchoalveolar lavage (BAL) fluid, and wet-to-dry lung weight ratio, pulmonary permeability index, BAL protein and expression of inducible nitric oxide synthase (iNOS) and nitrotyrosine (NT).

Results: Compared with the endotoxaemic group, both the pre- and simultaneous treatment groups showed significantly improved 5 h survival rates, and attenuated endotoxin-induced increased BAL fluid NO(2-) /NO(3-) and TNF-alpha, iNOS mRNA and NT expression in lung tissue, and decreased pulmonary microvascular permeability. These beneficial effects were blunted in the post-treatment group.

Conclusions: These findings indicate that early administration of propofol may provide protective effects against endotoxin-induced acute lung injury.

MeSH terms

  • Anesthetics, Intravenous / therapeutic use*
  • Animals
  • Blotting, Western
  • Bronchoalveolar Lavage Fluid / chemistry
  • Drug Administration Schedule
  • Lipopolysaccharides
  • Male
  • Propofol / therapeutic use*
  • Rats
  • Rats, Wistar
  • Respiratory Distress Syndrome / chemically induced
  • Respiratory Distress Syndrome / prevention & control*

Substances

  • Anesthetics, Intravenous
  • Lipopolysaccharides
  • Propofol